Sevelamer prescriptions after reporting of the dialysis clinical outcomes revisited (DCOR) trial findings: An analysis of 5,495 patients receiving maintenance dialysis in Ontario, Canada

American Journal of Kidney Diseases

Volumn 57, Issue 2, 2011, Pages 357-359

  Weir, Matthew A ^a   Jain, Arsh K ^a   Gomes, Tara ^b   Juurlink, David N ^b,c,d   Mamdani, Muhammad ^b,c,d,e   Li, Lihua ^a   Garg, Amit X ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CALCITRIOL; PHOSPHATE BINDING AGENT; SEVELAMER;

ACUTE KIDNEY FAILURE; CANADA; DIALYSIS; GERIATRIC PATIENT; HUMAN; LETTER; MEDICAL DECISION MAKING; PRESCRIPTION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CHELATING AGENTS; FEMALE; HUMANS; HYPERPHOSPHATEMIA; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; ONTARIO; PHYSICIAN'S PRACTICE PATTERNS; POLYAMINES; RENAL DIALYSIS;

EID: 78751606818     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2010.09.025     Document Type: Letter

References (9)

1. C.A. Jackevicius, G.M. Anderson, L. Leiter, and J.V. Tu Use of the statins in patients after acute myocardial infarction: does evidence change practice? Arch Intern Med 161 2 2001 183 188
2. P.C. Austin, M.M. Mamdani, K. Tu, and L. Jaakkimainen Prescriptions for estrogen replacement therapy in Ontario before and after publication of the Womens Health Initiative Study JAMA 289 24 2003 3241 3242
3. K. Tu, M.M. Mamdani, R.M. Jacka, N.J. Forde, D.M. Rothwell, and J.V. Tu The striking effect of the Heart Outcomes Prevention Evaluation (HOPE) on ramipril prescribing in Ontario CMAJ 168 5 2003 553 557
4. N.N. Lam, A.K. Jain, and D.G. Hackam Results of a randomized controlled trial on statin use in dialysis patients had no influence on statin prescription Kidney Int 76 2009 1172 1179
5. W.N. Suki, R. Zabaneh, and J.L. Cangiano Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients Kidney Int 72 9 2007 1130 1137
6. A.R. Levy, B.J. OBrien, and C. Sellors Coding accuracy of administrative drug claims in the Ontario Drug Benefit database Can J Clin Pharmacol 10 2 2003 67 71
7. W.L. St. Peter, J. Liu, E. Weinhandl, and Q. Fan A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: a secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data Am J Kidney Dis 51 3 2008 445 454
8. W.C. Winkelmayer, and M. Tonelli Phosphate binder choice in dialysis patients: a call for evidence-based rather than marketing-based clinical practice Am J Kidney Dis 51 3 2008 362 365
9. D. Juurlink, C. Preyra, and R. Croxford Canadian Institute for Health Information Discharge Abstract Database: A Validation Study. 2006 Institute for Clinical Evaluative Sciences Toronto, Canada